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Conclusion. Clinical outcomes of CSI schedule with HT are favorable, with lower resultant doses to the normal tissue. Acute and
late toxicities are tolerable without severe late side effects.
http://dx.doi.org/10.1016/j.rpor.2013.03.389
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Introduction. On the 16th of January 2012, the Spanish Association Against Cancer (AECC) implemented the volunteer program
“Carrito Don Amable” in the Radiation Oncology Service of Meixoeiro Hospital of the University Hospital Center of Vigo (CHUVI)
with the aim of taking care the needs that are not met under the healthcare scope, both for the oncologic patients and for his
relatives. One year after its implementation, it will be carried out a quality assessment of the program, taking into account the
importance and the assessment of the attributes made by patients and relatives that are program beneﬁciaries.
Objective. Analyzing the quality of the program “Carrito DonAmable” of the AECC, implemented in the RadiationOncology Service
of the CHUVI through the IPA Technique (Importance-Performance Analysis) in a representative sample of program beneﬁciaries.
Methods. The IPA is a quality assessment technique based on the analysis of expectation together with the assessment of the
attributes of the applicable service. In this study, it is implemented a questionnaire fulﬁlled by a statistically signiﬁcant sample
of the patients and relatives beneﬁciaries of the program.
Results and conclusions. Quadrant graphics will represent those attributes of the program that could be improved, those that will
be improved as a priority, those attributes that could imply a waste of resources or those of low priority. We will measure the
general success of the program assessed by its beneﬁciaries, the patients and relatives.
http://dx.doi.org/10.1016/j.rpor.2013.03.390
Quality of life data as prognostic indicators of survival in patients withmelanoma: An overview of our experience
C. Rodriguez Cerdeira1, A. Molares Vila2, V. Mun˜oz Garzon3
1 CHUVI, Dermatology, Spain
2 Universidad Vigo, Quimica Analitica, Spain
3 CHUVI, Radiation Oncology, Spain
Melanoma is a cancer that develops in melanocytes, the pigment cells present in the skin. It can be more serious than the other
forms of skin cancer because it may spread to other parts of the body (metastasize) and cause serious illness and death. About
40,000 new cases of melanoma are diagnosed in the United States every year. Health-related quality of life and survival are two
important outcome measures in melanoma research and practice. The aim of this presentation is to examine the relationship
between quality of life data and survival time in patientswithmelanomausing a general, validated dermatology QOL instrument:
the Dermatology Life Quality Index (DLQI). A total of 25 patients with melanoma were studied on the relationship between
quality of life and survival and we were found to be relevant and that were further examined. With few exceptions, the ﬁndings
showed that quality of life data or some aspects of quality of life measures were signiﬁcant independent predictors of survival
duration. Global quality of life, functioning domains and symptom scores – such as appetite loss, fatigue and pain – were the
most important indicators, individually or in combination, for predicting survival times in cancer patients after adjusting for one
or more demographic and known clinical prognostic factors. This review provides evidence for a positive relationship between
quality of life data or some quality of life measures and the survival duration of cancer patients. Pre-treatment (baseline) quality
of life data appeared to provide the most reliable information for helping clinicians to establish prognostic criteria for treating
their patients. It is recommended that future studies should use valid instruments, apply sound methodological approaches and
adequate multivariate statistical analyses adjusted for socio-demographic characteristics and known clinical prognostic factors
with a satisfactory validation strategy.
http://dx.doi.org/10.1016/j.rpor.2013.03.391
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Background. Delayed complications should be taken into account for treatment and routine follow-up of patients with soft tissue
sarcomas (STS), in order to prevent alterations in bone growth, osteitis, or secondary stress fractures.
